be_ixf;ym_202405 d_04; ct_50

Latest Insights on TOI

abbvie stock Profit From AbbVie’s Struggles Today Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
Of the people, by the people, for the people … well, half of us, at least. Maybe smartphone voting will change that? Voting Gets Lazy; Cash-Craving Comcast; Broadcom Bites the Apple
by Joseph Hargett January 24, 2020 Great Stuff
Friday Four Play: The “Getting Lazy” Edition Lazy. The entire country is lazy. We have amazing freedoms in this country … freedoms that are the envy of the world: freedom of speech, freedom of the press, freedom of religion, the right to bear arms, et cetera. But the most important of all? The freedom (and […]
Biotech. All those big scary words that have no real-world meaning to investors, but the $775 billion market should pique your interest. Sometimes, It’s Lupus; Sage’s Depressing Results
by Joseph Hargett December 5, 2019 Great Stuff
The Right Prescription for Massive Returns Today, dear readers, we’re going to cover a topic I just know you all love and adore: biotechnology. I can hear the groans already … and I get it. All those big scary words that have no real meaning to you at all. It’s like they’re talking about some […]
2020 earnings season This Is THE Options Trading Strategy for Earnings Season in 2020 Companies announce their earnings four times a year. Investors speculate on how a stock will move based on earnings — but doing so is a bad habit. With this approach, though, you don’t make a move until after companies report earnings. Anthony Planas talks about this revolutionary strategy that will change how you make money. (3-minute read)
Investing for Value or Growth? Don’t Choose 1 … Get Both I encourage you to enjoy the best of both worlds. You can do that by buying this reasonably priced stock that’s growing too.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"Since I started following your secret over your multiple publications, my $659,000 account is up to $715,000 in just 2 months. I’m up $56,000 in one month alone."

- Will O.

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

Share This